Oculoplastics

Teprotumumab treatment effect may be due to IGF-1 signaling disruption

New study data presented at AAO 2022 reveals a specific molecular signature for acute and chronic thyroid eye disease. During a presentation, Shoaib Ugradar, MD shared the results of entire genome RNA sequencing and pathway analysis in orbital tissue from patients with acute (n = 8) and chronic (n =...